Abstract

Alzheimer’s disease (AD) is the most common form of dementia, characterized by accumulation of amyloid β (Aβ) and neurofibrillary tangles. Oxidative stress and inflammation are considered to play an important role in the development and progression of AD. However, the extent to which these events contribute to the Aβ pathologies remains unclear. We performed inter-species comparative gene expression profiling between AD patient brains and the AppNL-G-F/NL-G-F and 3xTg-AD-H mouse models. Genes commonly altered in AppNL-G-F/NL-G-F and human AD cortices correlated with the inflammatory response or immunological disease. Among them, expression of AD-related genes (C4a/C4b, Cd74, Ctss, Gfap, Nfe2l2, Phyhd1, S100b, Tf, Tgfbr2, and Vim) was increased in the AppNL-G-F/NL-G-F cortex as Aβ amyloidosis progressed with exacerbated gliosis, while genes commonly altered in the 3xTg-AD-H and human AD cortices correlated with neurological disease. The AppNL-G-F/NL-G-F cortex also had altered expression of genes (Abi3, Apoe, Bin2, Cd33, Ctsc, Dock2, Fcer1g, Frmd6, Hck, Inpp5D, Ly86, Plcg2, Trem2, Tyrobp) defined as risk factors for AD by genome-wide association study or identified as genetic nodes in late-onset AD. These results suggest a strong correlation between cortical Aβ amyloidosis and the neuroinflammatory response and provide a better understanding of the involvement of gender effects in the development of AD.

Details

Title
Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
Author
Castillo, Erika 1 ; Leon, Julio 2 ; Mazzei Guianfranco 1   VIAFID ORCID Logo  ; Abolhassani Nona 1 ; Haruyama Naoki 1 ; Saito, Takashi 3   VIAFID ORCID Logo  ; Saido Takaomi 3 ; Hokama Masaaki 4 ; Iwaki Toru 5   VIAFID ORCID Logo  ; Ohara Tomoyuki 6 ; Ninomiya Toshiharu 7 ; Kiyohara Yutaka 8 ; Sakumi Kunihiko 1 ; LaFerla, Frank M 9 ; Nakabeppu Yusaku 1   VIAFID ORCID Logo 

 Medical Institute of Bioregulation, Kyushu University, Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Medical Institute of Bioregulation, Kyushu University, Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849); University of California, San Francisco, Department of Neurology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 RIKEN Brain Science Institute, Laboratory for Proteolytic Neuroscience, Saitama, Japan (GRID:grid.474690.8) 
 Medical Institute of Bioregulation, Kyushu University, Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849); Japan Community Health Care Organization Kyushu Hospital, Department of Neurosurgery, Kitakyushu, Japan (GRID:grid.460253.6) 
 Graduate School of Medical Sciences, Kyushu University, Department of Neuropathology, Neurological Institute, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Graduate School of Medical Sciences, Kyushu University, Department of Neuropsychiatry, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Graduate School of Medical Sciences, Kyushu University, Department of Epidemiology and Public Health, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849) 
 Hisayama Research Institute for Lifestyle Diseases, Hisayama, Fukuoka, Japan (GRID:grid.482571.d) 
 University of California, Department of Neurobiology and Behavior, Irvine, USA (GRID:grid.266093.8) (ISNI:0000 0001 0668 7243) 
Publication year
2017
Publication date
2017
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2570657286
Copyright
© The Author(s) 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.